Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
A cardioplegia solution is a specialized fluid used to intentionally and temporarily stop the heart during certain cardiac operations. It protects the heart muscle while surgeons work in a still and relatively bloodless field. Many formulations contain enough potassium to produce reversible electrical arrest. The solution can be crystalloid based or mixed with the patient's blood.
read more about cardioplegia solution ...Cardioplegia solution is used during operations that require cardiopulmonary bypass and temporary interruption of coronary blood flow. Common settings include valve surgery, coronary artery bypass surgery, congenital heart procedures, and aortic operations. Arresting the heart reduces its oxygen and energy requirements during the ischemic period. The solution is part of a broader myocardial-protection strategy that can also include cooling and controlled reperfusion.
Potassium-rich cardioplegia changes the electrical activity of heart-muscle cells and produces a reversible diastolic arrest. The reduced mechanical activity lowers myocardial oxygen consumption. Cooling can further slow metabolism, while buffers, substrates, or other additives can help limit acidosis and cellular injury. Protection decreases over time, so additional doses can be required during longer procedures.
Cardioplegia can be classified as blood or crystalloid and as warm, cold, or tepid. It can be delivered forward through the coronary arteries, called antegrade delivery, or backward through the coronary sinus, called retrograde delivery. Some operations use both routes to improve distribution. The formulation, temperature, volume, pressure, and redosing interval depend on the procedure, patient, and surgical protocol.
Inadequate delivery can leave parts of the heart underprotected and increase the risk of ischemic injury. Excess potassium, poor temperature control, incorrect concentration, high delivery pressure, or prolonged arrest can also cause complications. Clinicians monitor electrical activity, pressure, temperature, timing, laboratory values, and heart function as circulation is restored. Cardioplegia solutions are prepared and administered only by specialized cardiac-surgery teams.
No. Cardioplegia creates a planned and reversible cardiac arrest under controlled surgical conditions. The purpose is to reduce injury while the heart's normal blood flow is temporarily interrupted.
Blood cardioplegia combines a cardioplegic solution with oxygen-carrying blood, while crystalloid cardioplegia uses a nonblood electrolyte solution. Each approach has different preparation, delivery, and myocardial-protection characteristics.
The surgical team restores coronary blood flow and allows the cardioplegic components to wash out. The heart can resume activity on its own or require pacing, defibrillation, or medication support.
The protective interval varies by formulation, temperature, dose, and patient. Some solutions require frequent redosing, while selected protocols are designed for a longer single-dose interval.
Cardioplegia. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK554463/. Date Accessed August 5, 2026.
Myocardial Protection. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK567795/. Date Accessed August 5, 2026.
Retrograde Cardioplegia. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK538289/. Date Accessed August 5, 2026.
Warm Blood Cardioplegia for Myocardial Protection. Journal of Cardiac Surgery (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC7328091/. Date Accessed August 5, 2026.
Cardioplegia in Open Heart Surgery: Age Matters. Journal of Clinical Medicine (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC9958799/. Date Accessed August 5, 2026.